PHARMACYTE BIOTECH, INC. Cash and Restricted Cash
PHARMACYTE BIOTECH, INC. (PMCB) had Cash and Restricted Cash of $17.74 million as of 2026-07-31, per its 10-Q filed 2026-09-14.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-09-14
- 2026-07-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $17.74M.
- 2026-04-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $18.60M.
- 2026-01-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $20.17M.
- 2025-10-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $15.41M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-07-31 | $17.74M 10-Q · filed 2026-09-14 |
| 2026-04-30 | $18.60M 10-Q · filed 2026-09-14 |
| 2026-01-31 | $20.17M 10-Q · filed 2026-03-17 |
| 2025-10-31 | $15.41M 10-Q · filed 2025-12-18 |
| 2025-07-31 | $13.18M 10-Q · filed 2026-09-14 |
| 2025-04-30 | $15.17M 10-Q · filed 2026-09-14 |
| 2025-01-31 | $16.38M 10-Q · filed 2026-03-17 |
| 2024-10-31 | $20.84M 10-Q · filed 2025-12-18 |
| 2024-07-31 | $32.64M 10-Q · filed 2025-09-15 |
| 2024-04-30 | $50.18M 10-K · filed 2026-07-29 |
| 2024-01-31 | $61.21M 10-Q · filed 2025-03-17 |
| 2023-10-31 | $73.43M 10-Q · filed 2024-12-13 |
| 2023-07-31 | $74.66M 10-Q · filed 2024-09-17 |
| 2023-04-30 | $68.04M 10-K · filed 2025-08-11 |
| 2023-01-31 | $72.64M 10-Q · filed 2024-03-18 |
| 2022-10-31 | $76.96M 10-Q · filed 2023-12-15 |
| 2022-07-31 | $82.23M 10-Q · filed 2023-09-18 |
| 2022-04-30 | $85.40M 10-K · filed 2024-08-13 |
| 2022-01-31 | $86.64M 10-Q · filed 2023-03-16 |
| 2021-10-31 | $86.94M 10-Q · filed 2022-12-14 |
| 2021-07-31 | $959.27K 10-Q · filed 2022-09-14 |
| 2021-04-30 | $2.20M 10-K · filed 2023-07-31 |
| 2021-01-31 | $3.09M 10-Q · filed 2022-03-15 |
| 2020-04-30 | $894.86K 10-K · filed 2022-07-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |